Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Statistical Center for HIV/AIDS Research & Prevention (SCHARP) at Fred Hutch is seeking a Clinical Data Manger III to work with Phase 1-3 clinical trial study teams to develop and deliver quality clinical trial data for the betterment of HIV research worldwide. The CDM III leads the SCHARP project/study team coordinating with both internal and external partners and collaborators to ensure the relevant data are collected to meet the needs of the project or research objectives.S/he uses best practices for project management. The CDM III is the primary SCHARP contact for protocol/project implementation, operation, and closeout phases and is responsible for communication, documentation, and providing training on data collection and management activities for domestic and international research sites.
S/he functions with minimal supervision with demonstrated decision-making ability in operational and technical matters within defined procedures and practices. The CDM III will have advanced knowledge of data management operations best practices and network-specific activities. S/he may participate in training and orientation of new CDMs when appropriate, and may serve as a CDM mentor.
Assignment of projects/trials is commensurate with previous experience and can be assigned across scientific areas or study phases. S/he will be coordinating larger, more complex studies and/or a larger volume of studies with minimal assistance.